NCT00324012View on ClinicalTrials.gov

Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Adrenocortical Carcinoma
Interventions
DRUG

cisplatin, taxotere

cisplatin 75 mg/m2 Taxotere 75 mg/m2

Trial Locations (1)

2100

Department of Oncology 5073, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT00324012 - Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma | Biotech Hunter | Biotech Hunter